agammaglobulinemia 1

Description

Agammaglobulinemia: A Rare Primary Immunodeficiency

Agammaglobulinemia, also known as hypogammaglobulinemia, is a rare primary immunodeficiency characterized by a profoundly low or absent serum antibodies and low or absent circulating B cells [5]. This condition affects the body's ability to produce antibodies, which are crucial for fighting off infections.

Types of Agammaglobulinemia

There are two congenital types of agammaglobulinemia: X-linked and autosomal recessive. The X-linked form is caused by a gene located on the X chromosome that makes it impossible for individuals with this condition to produce antibodies [6]. In contrast, the autosomal recessive form occurs when an individual inherits two copies of the mutated gene, one from each parent [3].

Characteristics and Symptoms

Agammaglobulinemia is characterized by recurrent bacterial infections in affected males during the first two years of life [6]. Individuals with this condition may also experience a range of symptoms, including:

  • Recurrent respiratory tract infections
  • Skin infections
  • Gastrointestinal infections
  • Increased susceptibility to viral infections

Causes and Diagnosis

Agammaglobulinemia is caused by mutations in genes that affect the production of antibodies. The diagnosis of agammaglobulinemia typically involves a combination of clinical evaluation, laboratory tests, and genetic analysis [7].

References: [1] Not provided (user query) [3] Context #3 [5] Context #5 [6] Context #6 [7] Context #7

Additional Characteristics

  • Recurrent respiratory tract infections
  • Skin infections
  • Gastrointestinal infections
  • Hypogammaglobulinemia
  • Increased susceptibility to viral infections
  • Agammaglobulinemia
  • Recurrent bacterial infections in affected males during the first two years of life

Signs and Symptoms

Common Signs and Symptoms of Agammaglobulinemia

Agammaglobulinemia, a rare genetic disorder, is characterized by an impaired immune system that makes it difficult for the body to fight off infections. The symptoms of this condition can vary in severity and may include:

  • Recurring Infections: Infants with agammaglobulinemia often develop frequent infections of the ears, throat, lungs, and sinuses [5].
  • Bronchitis and Pneumonia: People with this condition are prone to developing bronchitis and pneumonia due to their compromised immune system [3].
  • Diarrhea and Gastrointestinal Issues: Diarrhea is a common symptom of agammaglobulinemia, which can lead to gastrointestinal issues if left untreated [1].
  • Eye Infections (Conjunctivitis): Conjunctivitis, an eye infection, is another symptom that people with this condition may experience [3].
  • Middle Ear Infections (Otitis Media): Otitis media, a middle ear infection, can also occur in individuals with agammaglobulinemia [3].

These symptoms often start to appear around 6 months of age and can be severe if left untreated. It's essential for parents or caregivers to seek medical attention if they suspect that their child has this condition.

References:

[1] Context result 1 [2] Context result 2 [3] Context result 3 [5] Context result 5

Additional Symptoms

  • Recurring Infections
  • Bronchitis and Pneumonia
  • Diarrhea and Gastrointestinal Issues
  • Eye Infections (Conjunctivitis)
  • Middle Ear Infections (Otitis Media)

Diagnostic Tests

Diagnostic Tests for Agammaglobulinemia

Agammaglobulinemia, also known as X-linked agammaglobulinemia (XLA), is a rare genetic disorder characterized by the absence or low levels of immunoglobulins in the blood. Diagnosing this condition involves a combination of medical history, physical examination, and laboratory tests.

Blood Tests

  • Blood tests can determine whether you or your child have XLA by measuring the levels of immunoglobulins (IgG, IgA, IgM) [6].
  • A healthcare provider can perform blood tests to detect low levels of B-cells or immunoglobulins, which is a hallmark of XLA [5].

Genetic Testing

  • Genetic testing may be done to confirm the diagnosis of X-linked agammaglobulinemia but is not usually needed [8].
  • Testing is recommended for close relatives to determine if they carry the mutated gene.

Other Diagnostic Tests

  • A complete medical history and physical examination are essential in diagnosing XLA, including multiple blood tests to confirm low levels of immunoglobulins [7].

Note: The diagnosis of agammaglobulinemia should be considered in any individual (male or female) with recurrent or severe bacterial infections [4].

Additional Diagnostic Tests

  • Blood Tests
  • Other Diagnostic Tests
  • Genetic Testing

Treatment

Treatment Options for Agammaglobulinemia

Agammaglobulinemia, also known as X-linked agammaglobulinemia (XLA), is a rare genetic disorder characterized by the absence or near-absence of immunoglobulins in the blood. The primary treatment for this condition involves replacing these missing antibodies through various medications.

  • Intravenous Immunoglobulin (IVIG): IVIG is a standard treatment for agammaglobulinemia, where patients receive infusions of pre-formed antibodies to help boost their immune system. Typical doses range from 400-600 mg/kg/month, administered every 3-4 weeks [1].
  • Subcutaneous Immunoglobulin (SCIG): SCIG is another form of immunoglobulin replacement therapy that involves injecting the medication just under the skin.
  • Antibiotics: Aggressive treatment with antibiotics is crucial in preventing long-term complications from bacterial infections, which are common in patients with agammaglobulinemia [3].
  • Gammagard S-D (IgA < 1 mcg/ml): This is a specific type of IVIG solution used to treat or reduce symptoms of agammaglobulinemia.

While there is no curative treatment for XLA, consistent gammaglobulin therapy can achieve good disease control and prevent complications [6]. It's essential for patients with agammaglobulinemia to work closely with their healthcare providers to manage their condition effectively.

References: [1] May 13, 2024 — Treatment for XLA is IVIG. Typical doses are 400-600 mg/kg/mo given every 3-4 weeks. [3] Jul 8, 2019 — Aggressive treatment with antibiotics for bacterial infections may prevent long-term complications. [6] There is no curative treatment for XLA but good disease control can be achieved through consistent gammaglobulin therapy.

Recommended Medications

  • Antibiotics
  • Intravenous Immunoglobulin (IVIG)
  • Subcutaneous Immunoglobulin (SCIG)
  • ml)

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses of Agammaglobulinemia

Agammaglobulinemia, a group of inherited immune deficiencies characterized by low antibody levels in the blood, can be challenging to diagnose. The differential diagnoses for this condition include:

  • Autosomal Recessive or Dominant Agammaglobulinemia: This is a rare form of agammaglobulinemia that can occur in both males and females.
  • Common Variable Immunodeficiency (CVID): CVID is a type of primary immunodeficiency characterized by impaired antibody production, which can lead to recurrent infections.
  • Hyper IgM Syndrome: This is a rare genetic disorder that affects the immune system's ability to produce antibodies, leading to recurrent infections and other complications.
  • Severe Combined Immunodeficiency (SCID): SCID is a severe form of primary immunodeficiency characterized by a lack of functioning T cells and B cells, which can lead to life-threatening infections.

These conditions share similar symptoms with agammaglobulinemia, such as recurrent or severe bacterial infections. A careful investigation, including genetic testing and immune function studies, is necessary to differentiate these conditions from agammaglobulinemia [4][6].

In addition, X-linked agammaglobulinemia (XLA) in male patients can also be a differential diagnosis for primary agammaglobulinemia, as well as myelodysplasia or congenital infections [10].

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0081136
core#notation
DOID:0081136
oboInOwl#hasDbXref
MIM:601495
rdf-schema#label
agammaglobulinemia 1
IAO_0000115
An agammaglobulinemia that has_material_basis_in homozygous or compound heterozygous mutation in the mu heavy-chain gene (IGHM) on chromosome 14q32.
rdf-schema#subClassOf
t361691
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_3970
owl#annotatedSource
t361277

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.